Overview
Luca Roz practices in Milan, Italy. Mr. Roz is rated as a Distinguished expert by MediFind in the treatment of Large-Cell Lung Carcinoma. His top areas of expertise are Large-Cell Lung Carcinoma, Lung Cancer, Neuroendocrine Tumor, and Non-Small Cell Lung Cancer (NSCLC).
His clinical research consists of co-authoring 52 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Large-Cell Lung Carcinoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Large-Cell Lung CarcinomaMr. Roz isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung CancerMr. Roz isDistinguished. Learn about Lung Cancer.
- Advanced
- Neuroendocrine TumorMr. Roz isAdvanced. Learn about Neuroendocrine Tumor.
- Experienced
- Lung AdenocarcinomaMr. Roz isExperienced. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)Mr. Roz isExperienced. Learn about Small Cell Lung Cancer (SCLC).